(Q40789633)

23 September 2017

title

Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology (English)

1 reference

23 September 2017

0 references

1

M R Hilleman

1 reference

23 September 2017

publication date

1 August 1999

1 reference

23 September 2017

published in

Immunological Reviews

1 reference

23 September 2017

volume

170

1 reference

23 September 2017

page(s)

7-27

1 reference

Joseph-Alexandre Auzias-Turenne, Louis Pasteur, and early concepts of virulence, attenuation, and vaccination

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Laboratory studies on the 1950 outbreak of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Antibody response in volunteers to Asian influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Live, attenuated rubella-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Development of a purified poliomyelitis virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

The vacuolating virus, S.V. 40

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Human hepatitis B vaccine from recombinant yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Safety and Immunogenicity of a Live Attenuated Hepatitis A Virus Vaccine in Seronegative Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Hepatitis and hepatitis A vaccine: a glimpse of history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

The human antibody response to simultaneous injection of six specific polysaccharides of pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Live respiratory syncytial virus vaccine administered parenterally

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

IMMUNOLOGIC, CHEMOTHERAPEUTIC AND INTERFERON APPROACHES TO CONTROL OF VIRAL DISEASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

The business of science and the science of business in the quest for an AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Six decades of vaccine development--a personal history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Pneumococcus: the first one hundred years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Antigenic variation of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

New antigenic variant in Far East influenza epidemic, 1957.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Recovery of new agent from patients with acute respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Biophysical characterization of the RI (RI-67) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Electron microscopy of type 4 adenovirus strain R1-67

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Grouping and occurrence of RI (prototype RI-67) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Recovery of rubella virus from army recruits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Clinical and Laboratory Studies of KMcC Strain Live Attenuated Varicella Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Factors influencing tumor induction in hamsters by vacuolating virus, SV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Yeast recombinant hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Production of purified hepatitis B surface antigen from Alexander hepatoma cells grown in artificial capillary units

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Recovery of Hepatitis Agents in the Marmoset from Human Cases Occurring in Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Etiologic relationship of marmoset-propagated CR326 hepatitis A virus to hepatitis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Progress toward a live, attenuated human hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Haemophilus influenzae type b polysaccharide-protein conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Recovery of new viruses (coryzavirus) from cases of common cold in human adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Characterization and classification of ECHO 28-rhinovirus-coryzavirus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

ADDITIONAL RHINOVIRUS SEROTYPES

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Rhinovirus infection in nursery and kindergarten children. New rhinovirus serotype 54

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Attempt at immunization by oral feeding of live rhinoviruses in enteric-coated capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Purification and characterization of chick embryo interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

Interferon induction and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01325.X

10.1111/J.1600-065X.1999.TB01325.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference